Baku 15° C
COVID vaccine manufacturers to make billions from selling third dose
Business
- 26 September, 2021
- 07:43
Pfizer may receive $26 billion from the sales of the third dose of its coronavirus vaccine in 2022, Report informs with reference to the Morningstar financial company.
The company's sales forecast for this year is $4 billion.
Another vaccine maker, Moderna, might earn $2 billion this year and $14 billion next year.
At the same time, Morningstar analysts believe that sales might increase significantly next year as countries approve the third dose.
Author
Latest News
09:11
Photo
First Vice-President of Azerbaijan Mehriban Aliyeva visits Vatican Apostolic Library
Foreign policy09:08
Photo
First Vice-President Mehriban Aliyeva inspects restoration progress at Saint Peter's Basilica
Foreign policy09:05
First Vice-President Mehriban Aliyeva, along with family members, attend tree planting ceremony in Vatican Gardens
Foreign policy09:03
Photo
First Vice-President Mehriban Aliyeva meets President of Governorate of Vatican City State
Foreign policy08:50
Photo
First Vice-President of Azerbaijan Mehriban Aliyeva meets Vatican's Secretary of State
Foreign policy08:46
Poland's LOT Airlines aircraft makes emergency landing in Baku
Infrastructure00:05
Five years since liberation of Khudafarin bridge from occupation
Karabakh00:00
Azerbaijan marks 34th anniversary of restored independence
Domestic policy20:55
Photo